MediWound (MDWD) Treasury Shares (2013 - 2014)
MediWound's (MDWD) quarterly Treasury Shares came in at -$34.6 million in Q1 2014, little changed quarter-over-quarter from -$34.6 million in Q4 2013.
MediWound (MDWD) Treasury Shares (2013 - 2014) Analysis & Trends
MediWound's Treasury Shares history runs 2 years deep, the most recent figure standing at -$34.6 million for Q1 2014.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to -$34.6 million in Q1 2014; TTM through Mar 2014 was -$34.6 million, a N/A change from a year earlier, with the FY2013 full-year figure at -$34.6 million, changed N/A from the prior year.
- Treasury Shares held at -$34.6 million in Q1 2014 per MDWD's latest filing, from -$34.6 million in the prior quarter.
- Across five years, Treasury Shares topped out at -$34.6 million in Q3 2013 and bottomed at -$34.6 million in Q3 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | -34.60 Mn |
| Mar 31, 2014 | -34.60 Mn |
| Dec 31, 2013 | -34.60 Mn |
| Dec 31, 2013 | -34.60 Mn |
| Sep 30, 2013 | -34.60 Mn |
| Sep 30, 2013 | -34.60 Mn |